Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetes ; 50(1): 143-9, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11147780

ABSTRACT

Bcl-2 mRNA expression was detected in rat blastocysts by in situ hybridization. The distribution of mRNA expression was rather heterogenous, with approximately 2% of high-expressing cells. In vitro exposure to 28 mmol/l D-glucose for 24 h resulted in a significant increase in the proportion of these cells compared with control embryos in either 6 mmol/l D-glucose or 28 mmol/l D+L-glucose. Heterogeneity in the expression of Bcl-2 was also observed at the protein level by immunocytochemistry. Exposure to 28 mmol/l D-glucose significantly increased the incidence of chromatin degradation (karyolysis) and nuclear fragmentation (karyorhexis), two nuclear markers of apoptosis in rat blastocysts. When two different antisense oligodeoxynucleotides designed to block Bcl-2 expression were added to 28 mmol/1 D-glucose, the incidence of karyolysis (but not karyorhexis) was increased compared with embryos in 28 mmol/l D-glucose alone. These data suggest that Bcl-2 is involved in the protective response against the induction of karyolysis in blastocysts on their exposure to high concentrations of D-glucose in vitro, whereas karyorhexis appears to result from the activation of an intracellular pathway that is independent of Bcl-2.


Subject(s)
Blastocyst/drug effects , Blastocyst/physiology , Glucose/pharmacology , Proto-Oncogene Proteins c-bcl-2/physiology , Animals , Blastocyst/metabolism , Culture Techniques , Dose-Response Relationship, Drug , Female , Oligonucleotides, Antisense/pharmacology , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/metabolism , Rats , Rats, Wistar
2.
Biol Reprod ; 63(3): 879-86, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10952935

ABSTRACT

In order to better understand how tumor necrosis factor (TNF)-alpha may contribute to the local regulation of uterine cell death, cultures of mouse uterine epithelial WEG-1 cells were exposed to TNF-alpha and observed at different time intervals. Earliest decrease in cell viability was observed after 31 h of exposure to 50 ng/ml mouse TNF-alpha and was associated with the expression of several markers of apoptosis. Treatment with human TNF-alpha or addition of a neutralizing antibody against TNF-alpha receptor protein 80 to mouse TNF-alpha resulted in attenuated induction of apoptosis, suggesting that coengagement of the two TNF-alpha receptor types is required for maximal impact. Ceramide analogs failed to replicate the effect of TNF-alpha and the stress-activated protein kinase signaling pathway was not activated by the cytokine. Treatment with mouse TNF-alpha resulted in an increase in nuclear factor (NF)kappaB activity that receded after 24 h. The impact of human TNF-alpha on NFkappaB activation was more moderate. Addition of either one of three different inhibitors of NFkappaB (SN50, PDTC, and A771726) to mouse TNF-alpha sensitized WEG-1 cells to the toxicity of the cytokine. Our data suggest that WEG-1 cells initiate their response to TNF-alpha with an increase in NFkappaB activation that may have transiently biased these cells toward cell death resistance.


Subject(s)
Apoptosis , NF-kappa B/metabolism , Proline/analogs & derivatives , Tumor Necrosis Factor-alpha/pharmacology , Uterus/cytology , Uterus/metabolism , Aniline Compounds/pharmacology , Animals , Cell Line , Ceramides/pharmacology , Crotonates , DNA Fragmentation , Female , Humans , Hydroxybutyrates/pharmacology , In Situ Nick-End Labeling , Mice , NF-kappa B/antagonists & inhibitors , Nitriles , Peptides/pharmacology , Proline/pharmacology , Signal Transduction , Thiocarbamates/pharmacology , Toluidines
3.
Cytokine ; 11(7): 500-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10419651

ABSTRACT

Previous observations have shown that tumour necrosis factor alpha (TNF-alpha) synthesis is increased in the uterus of diabetic rats and that the epithelial layer lining the uterine lumen is the major site of TNF-alpha over-production. In the present study, TNF-alpha secretion was found to be stimulated by high D-glucose levels in primary cultures of mouse uterine luminal cells but not in cultures of the mouse uterine epithelial WEG-1 cell line. Experiments were performed to investigate the possibility that non-epithelial cells may mediate the influence of high D-glucose on TNF-alpha production by uterine epithelial cells. Immunocytochemical analysis revealed the reproducible presence of a small proportion of macrophages in primary cultures. Macrophages of the RAW 264.7 cell line were found to secrete more interleukin (IL)-1beta (but not TNF-alpha) when cultured in high D-glucose. TNF-alpha production in WEG-1 cells was increased upon exposure to IL-1beta and both protein kinase-C and tyrosine kinase pathways appeared to be involved in TNF-alpha stimulation. Addition of IL-1 receptor antagonist to primary cultures partially abrogated the effect of high D-glucose. Since WEG-1 cells do not produce IL-1beta, the data lend support to the hypothesis that uterine epithelial cells synthesize high levels of TNF-alpha in response to hyperglycaemia via an increase in IL-1beta secretion by stromal macrophages.


Subject(s)
Epithelial Cells/metabolism , Glucose/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Uterus/cytology , Animals , Cells, Cultured/drug effects , Epithelial Cells/drug effects , Female , Hyperglycemia/physiopathology , Interleukin-1/pharmacology , Interleukin-1/physiology , Macrophages/drug effects , Mice , Tumor Necrosis Factor-alpha/biosynthesis , Uterus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...